Global Community

Catalysts Are there any products or services that could move sales or earnings meaningfully? Entry into the EV market with the Scorpio Electric X1 Are there any industry tailwinds this stock is benefitting or hindered from?

Catalysts: Stable Demand for Packaged Foods : General Mills operates in the consumer foods sector, which has seen consistent demand for packaged foods. The company’s diverse product portfolio, including ready-to-eat cereals, snacks, and baking mixes, positions it well to benefit from this trend.

Freegold Ventures Overview (Golden Summit Project – Alaska): Location: 20 miles from Fairbanks, accessible via paved road. Project: Golden Summit – 20 million oz gold at 0.9 gpt.

Key Takeaways Costco may be overvalued, but its stable profitability indicates that it can catch-up in five years Growing the number of warehouses still makes sense, despite the lower returns Its own Kirkland brand, and eComm will contribute to margin expansion The special dividend is a working capital optimization tactic that also incentivizes investors to hold Membership fee increases may degrade loyalty, and act as a negative catalyst for the stock Catalysts Kirkland Signature's Growing Presence on Shelves Could Increase Margins Costco is a customer-centric company, with a $300B market cap and $246B in annual revenue. Its substantial purchasing power allows it to negotiate favorable deals with suppliers, enabling it to pass on savings to its members.

Key Takeaways Expanding the customer base with large brands via the Shopify Plus subscriptions is a profitable way to grow the business. In my view, Shopify has a $32B software, and $15.4B payments market opportunity.

1. Digital Transformation Driving IT Demand Rising IT spending in India, Middle East, and emerging markets.

Baidu Inc. (NASDAQ: BIDU) is a leading Chinese technology company specializing in internet-related services and artificial intelligence (AI).

Monash IVF ( ASX: MVF ) Monash IVF Group Limited is a leading provider of assisted reproductive services in Australia and Malaysia. With over 50 years of experience, the company has been instrumental in pioneering fertility treatments, including achieving Australia's first IVF birth and the world's first pregnancy from a frozen embryo.

Consolidated Adjusted EBITDA: $103 million for Q4 2024; $444 million for the full year 2024. Gross Sales: $368 million for Q4 2024; nearly $1.5 billion for the full year 2024.